Emerald Clinical Trials, a global clinical research organisation (CRO), announced on Thursday that it has received the Best Clinical Trials Supplier Award: Outstanding Patient Recruitment & Engagement at the 2026 Asia-Pacific Biopharma Excellence Awards (ABEA).

Emerald said that this award highlights its ability to navigate the complex recruitment landscapes of the Asia-Pacific region, ensuring that life-changing therapies reach patients with both speed and compassion.

Chantal Elbayeh, executive director, Project Delivery at Emerald Clinical Trials, commented: "This recognition is a testament to our team's dedication to solving the most complex challenges in clinical development. By bridging the gap between innovative science and patient access, Emerald is not just facilitating trials -- we are facilitating hope. This award reinforces our role at the forefront of strengthening the biopharmaceutical ecosystem and advancing the availability of breakthrough therapies for patients worldwide."